Wednesday, September 2, 2009
A study of cholesterol lowering drugs found that bad cholesterol recommendations may be too high. What else did the study discover? Dr. Edward Hill tells us in today’s 60 Second Housecall.
A study by cardiologists indicated that current cholesterol recommendations may not be enough to help some people prevent death from heart disease.
The study of the cholesterol-lowering drugs called statins found that LDL, or bad, cholesterol levels should be less than 62 mg/dL, much lower than the current recommendation of 100, in order to get maximum benefit from cholesterol-lowering drugs.
More than 4,100 patients admitted with severe chest pain were randomly assigned to receive either “aggressive” or standard treatment with a cholesterol-lowering drug.
The study found that having very low cholesterol reduced death from any cause by 28 percent and fatal heart attacks by 18 percent.
After two years of treatment, patients receiving aggressive treatment lowered their LDL cholesterol to an average of 62 mg/dL, while the average post-treatment LDL level was 95 mg/dL in the less aggressively treated group.
Heart specialists estimate that 200 million Americans meet the current criteria for statin treatment, but only one in eight eligible patients is receiving treatment.
For North Mississippi Medical Center, I’m Dr. Edward Hill.